Nanograb
PrivateLast Round
Grant
Dec 13, 2023
Total Funding Raised
$500,000
Company Overview
Nanograb operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in December 2023.
Nanograb is a biotechnology company that develops a computational drug discovery platform using artificial intelligence to design targeted non-viral gene therapy vectors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanograb Comparables
Compare Nanograb with similar companies based on industry and business-model similarity.
No comparables are published for Nanograb. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Nanograb Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 13, 2023 | ||||
| Pre Seed | Jul 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanograb Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Recode Health Ventures | Pre Seed |
| Recode Health Ventures | Pre Seed |
| BlueYard Capital | Grant |
| Imperial College London | Pre Seed |
| Imperial Enterprise Lab | Pre Seed |
| Sterling Road | Pre Seed |
| Y Combinator | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2023
Received funding from BlueYard Capital and Nucleate.
For institutional investors. Book with your work email.
Nanograb Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanograb's valuation, stock price, and market status.
Is Nanograb a public or private company?
Nanograb is a private company.
What is the current stock price of Nanograb?
Nanograb is a private company, so its shares have no public market price. Caplight tracks Nanograb's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanograb worth (valuation)?
Valuation information for Nanograb is not publicly available.
Can I buy Nanograb stock?
Nanograb shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanograb's last funding round?
Nanograb's most recent funding round was Grant on December 13, 2023.
Who are the main investors in Nanograb?
Key investors in Nanograb include Recode Health Ventures, Recode Health Ventures, BlueYard Capital, Imperial College London, Imperial Enterprise Lab.
Will Nanograb IPO soon?
No public IPO plans have been announced for Nanograb.
How can I track Nanograb secondary market activity?
Caplight tracks bids, offers, and trades in Nanograb's shares on secondary markets.